{"id":20317,"date":"2026-10-01T15:35:09","date_gmt":"2026-10-01T08:35:09","guid":{"rendered":"https:\/\/www.vietstock.org\/?p=20317"},"modified":"2026-10-09T19:07:27","modified_gmt":"2026-10-09T12:07:27","slug":"dexamethasone-veterinary-medicine","status":"publish","type":"post","link":"https:\/\/www.vietstock.org\/en\/industry-news\/dexamethasone-veterinary-medicine\/","title":{"rendered":"Dexamethasone in Veterinary Medicine: Anti-Inflammatory Role, Risks, and Use Considerations"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Dexamethasone is a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive effects. In veterinary medicine, it may be used for certain inflammatory and allergic conditions as well as other specific clinical indications.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">It is a long-acting glucocorticoid with high anti-inflammatory potency and <\/span><b>very low mineralocorticoid activity<\/b><span style=\"font-weight: 400;\">. Because its effects are both potent and prolonged, dexamethasone may also cause significant adverse effects when used for inappropriate indications, at unsuitable doses, or for longer than necessary.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Importantly, dexamethasone should not be regarded simply as a <\/span><b>general fever-reducing medicine<\/b><span style=\"font-weight: 400;\"> or as a treatment for every inflammatory condition. Its use should take into account the underlying cause, animal species, pregnancy status, concurrent diseases, other medicines being administered, and veterinary guidance.<\/span><\/p>\n<h2><b>Key takeaways<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Dexamethasone is a synthetic glucocorticoid with potent anti-inflammatory activity, a long duration of action, and very low mineralocorticoid activity.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">It may be used for certain inflammatory, allergic, and other specific clinical conditions, but it does not replace treatment of the underlying cause.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">In anaphylactic shock, dexamethasone may have a supportive role in selected cases but does not replace epinephrine and appropriate emergency resuscitation.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">High doses or prolonged use may cause immunosuppression, metabolic disturbances, muscle wasting, suppression of the HPA axis, and an increased risk of infection.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Dexamethasone should not be combined with NSAIDs without professional guidance because the risk of gastrointestinal ulceration and bleeding may increase.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Pregnant animals and those with uncontrolled infection, diabetes, or gastrointestinal disease require careful assessment before use.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Dose and treatment duration must be based on the specific product, species, and intended use. A single mg\/kg dose should not be applied to every situation.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Withdrawal time is specific to each product and must be checked before meat, milk, or other food products enter the food chain.<\/span><\/li>\n<\/ul>\n<h2><b>1. What is dexamethasone, and how does it differ from other corticosteroids?<\/b><\/h2>\n<figure id=\"attachment_20301\" aria-describedby=\"caption-attachment-20301\" style=\"width: 773px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-20301\" src=\"https:\/\/www.vietstock.org\/wp-content\/uploads\/2026\/10\/Dexamethasone.jpg\" alt=\"Syringe labelled dexamethasone in a clinical setting\" width=\"783\" height=\"522\" srcset=\"https:\/\/www.vietstock.org\/wp-content\/uploads\/2026\/10\/Dexamethasone.jpg 612w, https:\/\/www.vietstock.org\/wp-content\/uploads\/2026\/10\/Dexamethasone-300x200.jpg 300w\" sizes=\"(max-width: 783px) 100vw, 783px\" \/><figcaption id=\"caption-attachment-20301\" class=\"wp-caption-text\">Dexamethasone is a synthetic glucocorticoid with potent anti-inflammatory activity, a long duration of action, and very low mineralocorticoid activity.<\/figcaption><\/figure>\n<h3><b>1.1. What type of corticosteroid is dexamethasone?<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Dexamethasone is a synthetic corticosteroid belonging to the <\/span><b>glucocorticoid<\/b><span style=\"font-weight: 400;\"> group.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">It is structurally related to cortisol, a natural hormone produced by the adrenal glands.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Compared with natural cortisol, dexamethasone has:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Much greater anti-inflammatory potency.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">A longer duration of action.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Very low mineralocorticoid activity.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">This means that dexamethasone causes less sodium and water retention than corticosteroids with stronger mineralocorticoid activity, while producing more potent anti-inflammatory and immunosuppressive effects.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Dexamethasone is generally classified as a <\/span><b>long-acting glucocorticoid<\/b><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The actual duration and intensity of its effects depend on:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Animal species.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Dose.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Route of administration.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Formulation.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Health status.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Treatment objective.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Its long duration of action can be useful in certain circumstances, but it may also make rapid adjustment more difficult if adverse effects occur.<\/span><\/p>\n<h3><b>1.2. Common formulations<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">In veterinary medicine, dexamethasone may be available in several formulations.<\/span><\/p>\n<p><b>Injectable solutions<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Depending on the product, permitted routes may include:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Intramuscular injection.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Intravenous injection.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Subcutaneous injection.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Routes of administration should not be changed unless the product label permits this.<\/span><\/p>\n<p><b>Eye or ear preparations<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Certain products may be used in small-animal veterinary medicine to control local inflammation.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Use should be based on an appropriate diagnosis because topical corticosteroids may worsen certain infections or corneal lesions when used incorrectly.<\/span><\/p>\n<p><b>Ointments and other topical formulations<\/b><\/p>\n<p><span style=\"font-weight: 400;\">These may be used for certain localised inflammatory or allergic skin conditions.<\/span><\/p>\n<p><b>Combination products<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Some products combine dexamethasone with antibiotics or other active ingredients.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The presence of a corticosteroid in a combination product does not mean that the product is appropriate for every inflammatory condition. The approved indication should always be followed.<\/span><\/p>\n<h3><b>1.3. Dexamethasone compared with other corticosteroids<\/b><\/h3>\n<table>\n<tbody>\n<tr>\n<td><b>Medicine<\/b><\/td>\n<td><b>Relative anti-inflammatory potency<\/b><\/td>\n<td><b>Duration of action<\/b><\/td>\n<td><b>Mineralocorticoid activity<\/b><\/td>\n<td><b>Potential for HPA-axis suppression with prolonged use<\/b><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Dexamethasone<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Very high<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Long<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Very low<\/span><\/td>\n<td><span style=\"font-weight: 400;\">High<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Betamethasone<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Very high<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Long<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Very low<\/span><\/td>\n<td><span style=\"font-weight: 400;\">High<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Prednisolone<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Moderate<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Intermediate<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Low<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Moderate<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Prednisone<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Moderate<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Intermediate<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Low<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Moderate<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Methylprednisolone<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Moderate<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Intermediate<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Very low<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Moderate<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Hydrocortisone<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Lower<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Short<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Moderate<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Lower<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><i><span style=\"font-weight: 400;\">This table provides a relative comparison only. Potency and duration of action may vary according to species, formulation, and intended use.<\/span><\/i><\/p>\n<p><span style=\"font-weight: 400;\">Potential advantages of dexamethasone include:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Potent anti-inflammatory activity.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Long duration of action.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Very low mineralocorticoid activity.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Availability in several formulations.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Potential usefulness in certain conditions requiring strong control of inflammation.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Important limitations include:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Potent immunosuppressive effects.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Long duration of action, which may make rapid adjustment more difficult.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Potential metabolic and reproductive effects.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Suppression of the HPA axis with prolonged use.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Residue considerations in food-producing animals.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Unsuitability for unsupervised repeated or prolonged use.<\/span><\/li>\n<\/ul>\n<h2><b>2. Mechanism of action and effects of dexamethasone on the body<\/b><\/h2>\n<h3><b>2.1. Anti-inflammatory and anti-allergic mechanisms<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Dexamethasone crosses the cell membrane and binds to glucocorticoid receptors in the cytoplasm.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The drug\u2013receptor complex then enters the cell nucleus and alters the expression of multiple genes involved in the inflammatory response.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">These effects reduce the production or activity of inflammatory mediators, including:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Pro-inflammatory cytokines.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Prostaglandins.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Leukotrienes.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Other mediators involved in inflammation.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Dexamethasone may also:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Reduce vascular permeability.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Reduce oedema.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Limit the accumulation of inflammatory cells.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Suppress the activity of certain immune cells.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">As a result, dexamethasone may reduce swelling, inflammation, and allergic responses relatively quickly in appropriate clinical conditions.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">However, improvement in clinical signs does not mean that the underlying cause has been controlled.<\/span><\/p>\n<h3><b>2.2. Effects on the immune system and HPA axis<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Dexamethasone can suppress immune responses.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The risk increases with:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Higher doses.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Prolonged treatment.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Repeated use.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Existing infectious disease.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Pre-existing immune compromise.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Possible consequences include:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Reduced leukocyte activity.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Reduced immune responses.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Increased risk of opportunistic infections.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Masking of clinical signs of infection.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Reduced vaccine response in some circumstances.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Dexamethasone may also suppress the:<\/span><\/p>\n<p><b>Hypothalamic\u2013pituitary\u2013adrenal (HPA) axis.<\/b><\/p>\n<p><span style=\"font-weight: 400;\">With prolonged glucocorticoid use, endogenous cortisol production may decrease.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">For this reason, some animals treated for prolonged periods may require gradual dose reduction rather than abrupt discontinuation.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Not every short course requires tapering. Whether tapering is needed depends on the dose, duration of treatment, disease, and veterinary assessment.<\/span><\/p>\n<h3><b>2.3. Effects on metabolism, muscle, and bone<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Dexamethasone can increase glucose production and reduce glucose utilisation in certain tissues.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Possible consequences include:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Hyperglycaemia.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">More difficult diabetes control.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Changes in energy metabolism.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Prolonged glucocorticoid exposure may also increase protein catabolism, potentially leading to:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Muscle wasting.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Loss of muscle mass.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Reduced body condition.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Slower tissue recovery.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">In the skeletal system, prolonged corticosteroid use may affect calcium metabolism and bone formation, potentially increasing the risk of reduced bone density in certain species or clinical conditions.<\/span><\/p>\n<h2><b>3. When may dexamethasone be used?<\/b><\/h2>\n<figure id=\"attachment_20304\" aria-describedby=\"caption-attachment-20304\" style=\"width: 745px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-20304\" src=\"https:\/\/www.vietstock.org\/wp-content\/uploads\/2026\/10\/istockphoto-1215319974-612x612-1.jpg\" alt=\"Dexamethasone vial and syringe prepared for clinical use\" width=\"755\" height=\"524\" srcset=\"https:\/\/www.vietstock.org\/wp-content\/uploads\/2026\/10\/istockphoto-1215319974-612x612-1.jpg 612w, https:\/\/www.vietstock.org\/wp-content\/uploads\/2026\/10\/istockphoto-1215319974-612x612-1-300x208.jpg 300w\" sizes=\"(max-width: 755px) 100vw, 755px\" \/><figcaption id=\"caption-attachment-20304\" class=\"wp-caption-text\">Dexamethasone may be used for certain inflammatory, allergic, and other clinical conditions, but the underlying cause should be identified and managed appropriately.<\/figcaption><\/figure>\n<h3><b>3.1. Inflammation, allergic reactions, and certain acute conditions<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">A veterinarian may consider dexamethasone in certain situations such as:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Severe allergic reactions.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Oedema associated with inflammatory responses.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Certain inflammatory conditions involving joints, tendons, or soft tissue.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Certain neurological inflammatory conditions.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Certain inflammatory airway diseases where control of inflammation is required.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">This list should not be interpreted to mean that every condition described as \u201cinflammation\u201d requires a corticosteroid.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Where inflammation is associated with:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Bacterial infection.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Viral infection.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Fungal infection.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Parasitic disease.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">the underlying cause should be identified and managed appropriately.<\/span><\/p>\n<h3><b>3.2. Anaphylactic shock<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">In anaphylactic shock, dexamethasone is <\/span><b>not the primary emergency treatment<\/b><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Epinephrine, together with airway management, respiratory and circulatory support, and other necessary resuscitation measures, forms the basis of emergency care.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Corticosteroids may have a supportive role in certain cases, such as helping manage prolonged inflammatory responses or where veterinary assessment supports their use.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Epinephrine should not be delayed while waiting for dexamethasone to take effect.<\/span><\/p>\n<h3><b>3.3. Respiratory disease<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Dexamethasone may be used in certain respiratory conditions involving significant inflammation or oedema.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">However:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">It does not kill bacteria.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">It does not treat viruses.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">It may reduce clinical signs while the infectious agent remains present.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Dexamethasone should therefore not be used as a general treatment for every case of coughing, respiratory difficulty, or pneumonia.<\/span><\/p>\n<h3><b>3.4. Ketosis in dairy cattle<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Glucocorticoids <\/span><b>may be used as part of certain supportive treatment approaches for cows with ketosis<\/b><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">However, the role of corticosteroids in ketosis and related metabolic disorders in dairy cattle should be evaluated carefully.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Dexamethasone should not be considered the foundation of treatment for every case of ketosis.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Management should take into account:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Energy status.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Degree of reduced feed intake.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Ketone concentrations.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Blood glucose.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Liver status.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Concurrent postpartum diseases.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Veterinary assessment.<\/span><\/li>\n<\/ul>\n<h3><b>3.5. Obstetric use<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Dexamethasone may be used in certain professionally managed protocols to induce parturition in cattle at an appropriate stage of pregnancy.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">This is not a procedure that should be undertaken independently on farm.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Corticosteroid-induced parturition may be associated with risks such as:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Retained placenta.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Effects on calf health.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Postpartum complications.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Effects on maternal health.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">It should therefore only be performed for a clear clinical purpose and under veterinary supervision.<\/span><\/p>\n<h3><b>3.6. Species-specific considerations<\/b><\/h3>\n<p><b>Cattle<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Some dexamethasone products may be authorised for inflammatory or allergic conditions and other specific indications.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In dairy cattle, particular attention should be paid to:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Pregnancy status.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Metabolic disease.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Product indication.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Milk and meat withdrawal times.<\/span><\/li>\n<\/ul>\n<p><b>Pigs<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Dexamethasone may be considered for certain inflammatory or allergic conditions, but it should not be used routinely as supportive medication for every disease episode.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The risk of immunosuppression requires particular caution in herds affected by infectious disease.<\/span><\/p>\n<p><b>Poultry<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Dexamethasone is not a medicine that should be used routinely in commercial poultry production.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Where exceptional use is considered, the product, indication, and food-safety requirements should be checked carefully.<\/span><\/p>\n<p><b>Dogs and cats<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Dexamethasone is used for a range of inflammatory, allergic, immune-mediated, and neurological conditions.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">However, treatment protocols in dogs and cats differ substantially from those used in livestock, so doses or treatment durations should not be transferred between species.<\/span><\/p>\n<h2><b>4. When may dexamethasone be appropriate, and when should another medicine be considered?<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Dexamethasone may be considered when treatment requires:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Potent glucocorticoid activity.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Control of a significant inflammatory response.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Low mineralocorticoid activity.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">A prolonged effect that is appropriate for the treatment objective.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">However, treatment decisions should not follow the logic:<\/span><\/p>\n<p><span style=\"font-weight: 400;\">NSAID does not work \u2192 immediately switch to dexamethasone.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">NSAIDs and corticosteroids differ in:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Mechanism of action.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Indications.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Adverse-effect profiles.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">For conditions requiring longer-term treatment, an intermediate-acting corticosteroid may sometimes allow easier dose adjustment than dexamethasone.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Possible alternatives may include prednisolone or methylprednisolone, depending on:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Species.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Disease.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Route of administration.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Need for dose adjustment.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Risk of adverse effects.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Corticosteroids should not be switched independently because relative potency and duration of action differ considerably between products.<\/span><\/p>\n<h2><b>5. Principles of dosing and monitoring during treatment<\/b><\/h2>\n<figure id=\"attachment_20306\" aria-describedby=\"caption-attachment-20306\" style=\"width: 961px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-20306\" src=\"https:\/\/www.vietstock.org\/wp-content\/uploads\/2026\/10\/istockphoto-1302987901-612x612-1.jpg\" alt=\"Healthcare professional examining a medicine vial before treatment\" width=\"971\" height=\"546\" srcset=\"https:\/\/www.vietstock.org\/wp-content\/uploads\/2026\/10\/istockphoto-1302987901-612x612-1.jpg 612w, https:\/\/www.vietstock.org\/wp-content\/uploads\/2026\/10\/istockphoto-1302987901-612x612-1-300x169.jpg 300w\" sizes=\"(max-width: 971px) 100vw, 971px\" \/><figcaption id=\"caption-attachment-20306\" class=\"wp-caption-text\">Dexamethasone dosing in veterinary medicine depends on the animal species, treatment objective, formulation, and route of administration rather than a single universal dose.<\/figcaption><\/figure>\n<h3><b>5.1. Dose depends on the treatment objective<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Dexamethasone dosing varies considerably depending on its intended use, for example:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Anti-inflammatory treatment.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Immunosuppression.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Endocrine diagnostic testing.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Obstetric indications.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Other specialised clinical uses.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">For this reason, a single mg\/kg dosing table should not be applied to every situation.<\/span><\/p>\n<table>\n<tbody>\n<tr>\n<td><b>Species<\/b><\/td>\n<td><b>General principle<\/b><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Cattle<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Follow the specific product, indication, and veterinary guidance<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Pigs<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Follow the specific product and approved indication<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Dogs and cats<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Dose may vary considerably according to the therapeutic or diagnostic purpose<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Poultry<\/span><\/td>\n<td><span style=\"font-weight: 400;\">No universal dose should be applied; use only where an appropriate product and indication exist<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span style=\"font-weight: 400;\">General principles include:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Use the lowest effective dose appropriate for the indication.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Use the medicine only for as long as necessary.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Do not independently increase the dose when the response is lower than expected.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Do not independently prolong treatment.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Do not apply a dose intended for one species to another.<\/span><\/li>\n<\/ul>\n<h3><b>5.2. Monitoring treatment response<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Depending on the condition, monitoring may include:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Degree of inflammation and oedema.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Pain.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Respiratory rate.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Body temperature.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Feed and water intake.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">General condition.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Signs of infection.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Blood glucose in animals at risk.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Milk production and metabolic status in dairy cattle where relevant.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">There is no universal <\/span><b>48\u201372-hour<\/b><span style=\"font-weight: 400;\"> assessment point that applies to every dexamethasone indication.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">If the animal does not achieve the expected response for the condition and treatment regimen being used, or develops:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Recurrent fever.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Infection.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Metabolic disturbances.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Adverse effects.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">the treatment plan should be reassessed rather than simply increasing the dose or extending therapy.<\/span><\/p>\n<h3><b>5.3. Discontinuation after prolonged treatment<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">After prolonged treatment or use at immunosuppressive doses, dexamethasone should not be stopped abruptly without appropriate assessment.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In some cases, a veterinarian may recommend gradual dose reduction to allow the HPA axis to recover.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Tapering should not be applied automatically to every short treatment course.<\/span><\/p>\n<h2><b>6. Adverse effects and risks associated with prolonged use<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Adverse effects depend on:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Species.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Dose.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Duration of treatment.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Route of administration.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Underlying disease.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Some effects may appear relatively early, including:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Hyperglycaemia.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Increased thirst.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Increased urination.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Changes in appetite.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Delayed wound healing.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Increased risk of infection.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">The degree of these effects varies between species.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">With prolonged use, potential risks may include:<\/span><\/p>\n<p><b>Immunosuppression<\/b><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Increased risk of opportunistic infection.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Reactivation of existing disease.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Masking of clinical signs of infection.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Reduced immune response.<\/span><\/li>\n<\/ul>\n<p><b>Reproductive effects<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Glucocorticoids may affect:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Pregnancy.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Timing of parturition.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Certain reproductive functions.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Risk varies considerably with species, stage of pregnancy, and product.<\/span><\/p>\n<p><b>Muscle wasting and changes in body condition<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Prolonged treatment may increase protein catabolism and reduce muscle mass.<\/span><\/p>\n<p><b>HPA-axis suppression<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Endogenous cortisol production may decrease after prolonged glucocorticoid treatment.<\/span><\/p>\n<p><b>Iatrogenic Cushing\u2019s syndrome<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Particularly in dogs, prolonged glucocorticoid use may result in signs of iatrogenic hyperadrenocorticism, including:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Increased thirst and urination.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Increased appetite.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Muscle weakness.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Thin skin.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Changes in fat distribution.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Increased susceptibility to infection.<\/span><\/li>\n<\/ul>\n<h2><b>7. Common mistakes, contraindications, and drug interactions<\/b><\/h2>\n<figure id=\"attachment_20308\" aria-describedby=\"caption-attachment-20308\" style=\"width: 905px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-20308\" src=\"https:\/\/www.vietstock.org\/wp-content\/uploads\/2026\/10\/istockphoto-1252012541-612x612-1.jpg\" alt=\"Dexamethasone displayed with different tablets and capsules illustrating drug interaction risks\" width=\"915\" height=\"610\" srcset=\"https:\/\/www.vietstock.org\/wp-content\/uploads\/2026\/10\/istockphoto-1252012541-612x612-1.jpg 612w, https:\/\/www.vietstock.org\/wp-content\/uploads\/2026\/10\/istockphoto-1252012541-612x612-1-300x200.jpg 300w\" sizes=\"(max-width: 915px) 100vw, 915px\" \/><figcaption id=\"caption-attachment-20308\" class=\"wp-caption-text\">Dexamethasone should not be combined with NSAIDs without professional guidance because the risk of gastrointestinal ulceration and bleeding may increase.<\/figcaption><\/figure>\n<h3><b>7.1. Common mistakes<\/b><\/h3>\n<p><b>Using dexamethasone only to reduce fever<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Dexamethasone may suppress inflammation and make an animal appear to improve quickly.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">However, if the underlying cause is an infection, the pathogen may continue to progress while clinical signs are masked.<\/span><\/p>\n<p><b>Using it in pregnant animals without checking pregnancy status<\/b><\/p>\n<p><span style=\"font-weight: 400;\">In certain species and stages of pregnancy, dexamethasone may affect the foetus or induce parturition.<\/span><\/p>\n<p><b>Using high doses or repeatedly administering the medicine<\/b><\/p>\n<p><span style=\"font-weight: 400;\">This may increase:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Immunosuppression.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Metabolic disturbances.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">HPA-axis suppression.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Risk of adverse effects.<\/span><\/li>\n<\/ul>\n<p><b>Abruptly stopping prolonged treatment<\/b><\/p>\n<p><span style=\"font-weight: 400;\">This may increase the risk of adrenal insufficiency.<\/span><\/p>\n<h3><b>7.2. Situations requiring particular caution<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Careful veterinary assessment is important when an animal:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Has an uncontrolled systemic infection.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Is pregnant.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Has diabetes.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Has a disorder of glucose metabolism.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Has severe liver or kidney disease.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Has a history of gastrointestinal ulceration or bleeding.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Is receiving an NSAID.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Is receiving immunosuppressive treatment.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Is undergoing a vaccination programme and may require immunosuppressive doses of glucocorticoids.<\/b><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Young age should not automatically be treated as an absolute contraindication for every product. The decision should depend on species, disease, and specific product guidance.<\/span><\/p>\n<h3><b>7.3. Interactions with NSAIDs and other medicines<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Dexamethasone should not be combined independently with NSAIDs such as:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Flunixin.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Meloxicam.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Aspirin.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Other NSAIDs.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Combining a corticosteroid with an NSAID can substantially increase the risk of:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Gastrointestinal ulceration.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Gastrointestinal bleeding.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Serious gastrointestinal complications.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Other considerations include:<\/span><\/p>\n<p><b>Vaccines<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Immunosuppressive glucocorticoid doses may reduce vaccine responses. Vaccination timing should be assessed by a veterinarian.<\/span><\/p>\n<p><b>Diuretics<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Certain combinations may increase the risk of electrolyte abnormalities such as hypokalaemia.<\/span><\/p>\n<p><b>Insulin<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Dexamethasone can increase blood glucose, potentially making diabetes more difficult to control.<\/span><\/p>\n<p><b>Anti-infective treatment<\/b><\/p>\n<p><span style=\"font-weight: 400;\">If dexamethasone is used in the presence of infection, the infectious cause should be appropriately evaluated and managed.<\/span><\/p>\n<h2><b>8. Pregnancy, lactation, residues, and withdrawal time<\/b><\/h2>\n<h3><b>8.1. Pregnant animals<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Dexamethasone may affect pregnancy and can induce parturition in certain species.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">It should therefore only be used when:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">There is a clear indication.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Pregnancy status is known.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Stage of pregnancy has been assessed.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The benefit\u2013risk balance has been considered.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Veterinary supervision is available.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Dexamethasone should not be administered independently to pregnant cattle simply to \u201cbring on calving.\u201d<\/span><\/p>\n<h3><b>8.2. Lactating animals<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Where the product is authorised for lactating animals, users should follow:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Dose and route of administration.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Approved indication.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Milk withdrawal time.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Product instructions.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">If the label states that the product must not be used in animals producing milk for human consumption, an alternative milk withdrawal period should not be independently assumed to justify off-label use.<\/span><\/p>\n<h3><b>8.3. Dexamethasone residues in animal-derived foods<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">In food-producing animals, dexamethasone use requires consideration of residue risks in food products relevant to the species and authorised product.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">It should not be assumed that the active ingredient is broadly authorised for <\/span><b>meat, milk, or eggs across all species<\/b><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Permitted use and MRL requirements should be checked against the applicable regulations and the specific veterinary product.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In Vietnam, veterinary medicine MRLs in food should be checked against <\/span><b>Circular No. 24\/2013\/TT-BYT<\/b><span style=\"font-weight: 400;\"> together with relevant current technical regulations and other applicable legal documents.<\/span><\/p>\n<h3><b>8.4. Withdrawal time<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">A withdrawal time is the minimum period between the final administration of a medicine and the point at which food derived from the treated animal may enter the food chain.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Withdrawal time depends on:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Species.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Formulation.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Route of administration.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Treatment regimen.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Specific commercial product.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Type of food product.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">The withdrawal period of one dexamethasone product should not be applied to another.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">If the label does not authorise use in a particular food-producing group, an alternative withdrawal period should not be independently calculated to justify off-label use.<\/span><\/p>\n<h2><b>9. Checklist for safer dexamethasone use<\/b><\/h2>\n<figure id=\"attachment_20310\" aria-describedby=\"caption-attachment-20310\" style=\"width: 953px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-20310\" src=\"https:\/\/www.vietstock.org\/wp-content\/uploads\/2026\/10\/istockphoto-1286393353-612x612-1.jpg\" alt=\"Healthcare professional reviewing medicine and treatment records before use\" width=\"963\" height=\"642\" srcset=\"https:\/\/www.vietstock.org\/wp-content\/uploads\/2026\/10\/istockphoto-1286393353-612x612-1.jpg 612w, https:\/\/www.vietstock.org\/wp-content\/uploads\/2026\/10\/istockphoto-1286393353-612x612-1-300x200.jpg 300w\" sizes=\"(max-width: 963px) 100vw, 963px\" \/><figcaption id=\"caption-attachment-20310\" class=\"wp-caption-text\">A safer dexamethasone-use checklist should include the indication, pregnancy status, underlying infection risk, concurrent medicines, and withdrawal time in food-producing animals.<\/figcaption><\/figure>\n<h3><b>Before use<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Clearly identify why a corticosteroid is needed.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Confirm the correct product and authorised species.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Check whether the animal is pregnant.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Assess the possibility of an underlying infection.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Check for diabetes or metabolic disease where relevant.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Review any history of gastrointestinal ulceration.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Review concurrent medicines, especially NSAIDs.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Check withdrawal time in food-producing animals.<\/span><\/li>\n<\/ul>\n<h3><b>During treatment<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Record the product name.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Record the date of administration.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Record the route of administration.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Record the prescribed dose.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Monitor treatment response.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Monitor for signs of infection.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Monitor changes in appetite, drinking, and metabolism.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Do not independently increase the dose.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Do not independently add an NSAID.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Do not prolong treatment without reassessment.<\/span><\/li>\n<\/ul>\n<h3><b>After treatment<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Record the date of the final dose.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Taper the dose where specifically advised by a veterinarian after prolonged treatment.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Monitor for recurrence of disease or deterioration in body condition.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Check the withdrawal time for the exact product used.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Do not slaughter animals or collect food products before the permitted time.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Retain treatment records for traceability.<\/span><\/li>\n<\/ul>\n<h2><b>10. Frequently asked questions about veterinary dexamethasone<\/b><\/h2>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-20313\" src=\"https:\/\/www.vietstock.org\/wp-content\/uploads\/2026\/10\/istockphoto-1063301578-612x612-1.jpg\" alt=\"\" width=\"849\" height=\"566\" srcset=\"https:\/\/www.vietstock.org\/wp-content\/uploads\/2026\/10\/istockphoto-1063301578-612x612-1.jpg 612w, https:\/\/www.vietstock.org\/wp-content\/uploads\/2026\/10\/istockphoto-1063301578-612x612-1-300x200.jpg 300w\" sizes=\"(max-width: 849px) 100vw, 849px\" \/><\/p>\n<h3><b>Can dexamethasone reduce an animal\u2019s resistance to infection?<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Yes, particularly under certain conditions.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Dexamethasone can suppress immune function, especially when used:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">At high doses.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Repeatedly.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">For prolonged periods.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">This may increase the risk of infection or allow latent disease to become more clinically apparent.<\/span><\/p>\n<h3><b>Should dexamethasone be used in pregnant animals?<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">It should not be used independently without veterinary assessment.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Dexamethasone can affect pregnancy and may induce parturition in certain species.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Use should follow veterinary assessment of:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Stage of pregnancy.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Treatment objective.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Risks to the dam and foetus.<\/span><\/li>\n<\/ul>\n<h3><b>Can dexamethasone be used in lactating animals?<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">It depends on the product.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">It should only be used when the product is authorised for that production group and the specified milk withdrawal period is followed.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">If the label does not permit use in animals producing milk for human consumption, a withdrawal period should not be independently assumed to justify its use.<\/span><\/p>\n<h3><b>Is dexamethasone the primary emergency medicine for anaphylactic shock?<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">No.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In anaphylactic shock, epinephrine and appropriate emergency resuscitation measures form the basis of treatment.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Dexamethasone may only have a supportive role in certain situations following veterinary assessment.<\/span><\/p>\n<h3><b>Can dexamethasone replace an NSAID when anti-inflammatory treatment does not work?<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">It should not be switched independently.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">NSAIDs and corticosteroids have different mechanisms, indications, and risk profiles.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In particular, they should not be combined without professional guidance because the risk of gastrointestinal injury and bleeding may increase.<\/span><\/p>\n<h3><b>What are the major risks of dexamethasone misuse?<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Important risks may include:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Immunosuppression.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Masking or worsening infection.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Hyperglycaemia.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Muscle wasting.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Effects on pregnancy.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">HPA-axis suppression.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Iatrogenic Cushing\u2019s syndrome.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Increased risk of gastrointestinal ulceration when combined with NSAIDs.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Residue risks in food-producing animals.<\/span><\/li>\n<\/ul>\n<h2><b>Towards Safer Corticosteroid Use at VIETSTOCK 2026<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Dexamethasone has potent anti-inflammatory effects, but it is not appropriate for every inflammatory condition or case of fever in livestock. The risks of immunosuppression, masking infection, interaction with NSAIDs, effects on pregnancy, and residues in food-producing animals mean that its use should be linked to diagnosis, health monitoring, and appropriate professional guidance.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">At <\/span><b>VIETSTOCK 2026 \u2013 Vietnam\u2019s Premier International Feed, Livestock &amp; Meat Industry Show<\/b><span style=\"font-weight: 400;\">, farmers, veterinarians, and businesses can explore products, technologies, and solutions that support animal health and more effective livestock production. The event is expected to bring together more than <\/span><b>300 brands<\/b><span style=\"font-weight: 400;\">, over <\/span><b>10,000 sqm of exhibition area<\/b><span style=\"font-weight: 400;\">, and <\/span><b>13,000 trade visitors<\/b><span style=\"font-weight: 400;\"> from more than <\/span><b>40 countries and territories<\/b><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><b>For farms and veterinarians interested in safer use of anti-inflammatory medicines, participants can explore:<\/b><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Veterinary medicines and supportive treatment products:<\/b><span style=\"font-weight: 400;\"> exploring solutions for controlling inflammation, allergic reactions, and animal-health conditions according to practical clinical needs.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Health monitoring during treatment:<\/b><span style=\"font-weight: 400;\"> learning about technologies that support recording of disease progression, treatment response, and abnormalities requiring reassessment.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Safer medicine combinations:<\/b><span style=\"font-weight: 400;\"> exploring information and management solutions that support medicine-use history and help reduce combinations associated with greater adverse-effect risks.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Care during reproductive stages:<\/b><span style=\"font-weight: 400;\"> exploring solutions for monitoring the health of pregnant animals, postpartum animals, and other stages in which medicine use requires additional caution.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Residue control and traceability:<\/b><span style=\"font-weight: 400;\"> learning about solutions for treatment recording, withdrawal-time monitoring, and controlling animal-derived products before they enter the food chain.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">From a broader animal-health perspective, the <\/span><b>One Health Forum on 22 October 2026<\/b><span style=\"font-weight: 400;\"> is also a relevant programme at <\/span><b>VIETSTOCK 2026<\/b><span style=\"font-weight: 400;\">. The programme addresses connections between animal, human, and environmental health, together with biosecurity, disease control, and more sustainable livestock-production systems. This provides an opportunity for farmers and veterinarians to consider medicine use within the wider context of herd and flock health, disease prevention, and safety across the production chain.<\/span><\/p>\n<p><b>Date:<\/b><span style=\"font-weight: 400;\"> 21\u201323 October 2026<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span> <b>Venue:<\/b><span style=\"font-weight: 400;\"> Saigon Exhibition and Convention Center (SECC), 799 Nguyen Van Linh Street, Tan My Ward, Ho Chi Minh City, Vietnam<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span> <b>Event website:<\/b><a href=\"https:\/\/www.vietstock.org\/en\/\"> <span style=\"font-weight: 400;\">https:\/\/www.vietstock.org\/en\/<\/span><\/a><\/p>\n<p><strong>Register to visit now<\/strong>: <a href=\"http:\/\/Register to visit now: https:\/\/ers-vn.informa-info.com\/vs26\">https:\/\/ers-vn.informa-info.com\/vs26<\/a><\/p>\n<p><span style=\"font-weight: 400;\">\ud83d\udc49<\/span><a href=\"https:\/\/www.vietstock.org\/en\/event-features\/vietstock-2026-pre-registration-is-now-open-connect-with-the-future-of-livestock-production-and-animal-health-2\/\"> <b>VIETSTOCK 2026 Visitor Registration Information<\/b><\/a><\/p>\n<p><span style=\"font-weight: 400;\">\ud83d\udc49<\/span><a href=\"https:\/\/www.vietstock.org\/en\/event-features\/one-health-forum-at-vietstock-2026-advancing-sustainable-livestock-development\/\"> <b>Learn more about the One Health Forum<\/b><\/a><\/p>\n<p><b>Contact information:<\/b><\/p>\n<p><b>Exhibiting:<\/b><span style=\"font-weight: 400;\"> Ms. Sophie Nguyen \u2013 Sophie.nguyen@informa.com<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span> <b>Visitor Support:<\/b><span style=\"font-weight: 400;\"> Ms. Phuong \u2013 Phuong.C@informa.com<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span> <b>Marcom Support:<\/b><span style=\"font-weight: 400;\"> Ms. Anita Pham \u2013 Anita.pham@informa.com<\/span><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dexamethasone is a potent synthetic glucocorticoid used in veterinary medicine for certain inflammatory, allergic, and other clinical conditions. Learn about its uses, adverse effects, immunosuppression, drug interactions, pregnancy considerations, and withdrawal-time management.<\/p>\n","protected":false},"author":3,"featured_media":20687,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[45],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v15.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Dexamethasone in Veterinary Medicine: Uses, Risks &amp; Safety<\/title>\n<meta name=\"description\" content=\"Learn about dexamethasone in veterinary medicine, including its anti-inflammatory uses, side effects, drug interactions, pregnancy risks and withdrawal time.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.vietstock.org\/en\/industry-news\/dexamethasone-veterinary-medicine\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dexamethasone in Veterinary Medicine: Uses, Risks &amp; Safety\" \/>\n<meta property=\"og:description\" content=\"Learn about dexamethasone in veterinary medicine, including its anti-inflammatory uses, side effects, drug interactions, pregnancy risks and withdrawal time.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.vietstock.org\/en\/industry-news\/dexamethasone-veterinary-medicine\/\" \/>\n<meta property=\"og:site_name\" content=\"Vietstock Expo and Forum\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-01T08:35:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-09T12:07:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.vietstock.org\/wp-content\/uploads\/2026\/10\/dexamethasone-veterinary-medicine-uses-risks-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\">\n\t<meta name=\"twitter:data1\" content=\"18 minutes\">\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.vietstock.org\/#website\",\"url\":\"https:\/\/www.vietstock.org\/\",\"name\":\"Vietstock Expo and Forum\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":\"https:\/\/www.vietstock.org\/?s={search_term_string}\",\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.vietstock.org\/en\/industry-news\/dexamethasone-veterinary-medicine\/#primaryimage\",\"inLanguage\":\"en\",\"url\":\"https:\/\/www.vietstock.org\/wp-content\/uploads\/2026\/10\/dexamethasone-veterinary-medicine-uses-risks-2.jpg\",\"width\":1200,\"height\":675,\"caption\":\"Dexamethasone is a potent long-acting glucocorticoid used in veterinary medicine for certain inflammatory and allergic conditions, with important safety considerations related to immunosuppression and adverse effects.\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.vietstock.org\/en\/industry-news\/dexamethasone-veterinary-medicine\/#webpage\",\"url\":\"https:\/\/www.vietstock.org\/en\/industry-news\/dexamethasone-veterinary-medicine\/\",\"name\":\"Dexamethasone in Veterinary Medicine: Uses, Risks & Safety\",\"isPartOf\":{\"@id\":\"https:\/\/www.vietstock.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.vietstock.org\/en\/industry-news\/dexamethasone-veterinary-medicine\/#primaryimage\"},\"datePublished\":\"2026-10-01T08:35:09+00:00\",\"dateModified\":\"2026-10-09T12:07:27+00:00\",\"author\":{\"@id\":\"https:\/\/www.vietstock.org\/#\/schema\/person\/caaf897414eac1b9f130df4ddb9e34d6\"},\"description\":\"Learn about dexamethasone in veterinary medicine, including its anti-inflammatory uses, side effects, drug interactions, pregnancy risks and withdrawal time.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.vietstock.org\/en\/industry-news\/dexamethasone-veterinary-medicine\/#breadcrumb\"},\"inLanguage\":\"en\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.vietstock.org\/en\/industry-news\/dexamethasone-veterinary-medicine\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.vietstock.org\/en\/industry-news\/dexamethasone-veterinary-medicine\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"item\":{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.vietstock.org\/en\/\",\"url\":\"https:\/\/www.vietstock.org\/en\/\",\"name\":\"Trang ch\\u1ee7\"}},{\"@type\":\"ListItem\",\"position\":2,\"item\":{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.vietstock.org\/en\/industry-news\/dexamethasone-veterinary-medicine\/\",\"url\":\"https:\/\/www.vietstock.org\/en\/industry-news\/dexamethasone-veterinary-medicine\/\",\"name\":\"Dexamethasone in Veterinary Medicine: Anti-Inflammatory Role, Risks, and Use Considerations\"}}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.vietstock.org\/#\/schema\/person\/caaf897414eac1b9f130df4ddb9e34d6\",\"name\":\"vietwatercc\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.vietstock.org\/#personlogo\",\"inLanguage\":\"en\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1f8963694a555b77c6f4e61284c4fadb?s=96&d=mm&r=g\",\"caption\":\"vietwatercc\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","_links":{"self":[{"href":"https:\/\/www.vietstock.org\/en\/wp-json\/wp\/v2\/posts\/20317"}],"collection":[{"href":"https:\/\/www.vietstock.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vietstock.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vietstock.org\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vietstock.org\/en\/wp-json\/wp\/v2\/comments?post=20317"}],"version-history":[{"count":1,"href":"https:\/\/www.vietstock.org\/en\/wp-json\/wp\/v2\/posts\/20317\/revisions"}],"predecessor-version":[{"id":20642,"href":"https:\/\/www.vietstock.org\/en\/wp-json\/wp\/v2\/posts\/20317\/revisions\/20642"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vietstock.org\/en\/wp-json\/wp\/v2\/media\/20687"}],"wp:attachment":[{"href":"https:\/\/www.vietstock.org\/en\/wp-json\/wp\/v2\/media?parent=20317"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vietstock.org\/en\/wp-json\/wp\/v2\/categories?post=20317"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vietstock.org\/en\/wp-json\/wp\/v2\/tags?post=20317"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}